On August 25, 2022, Kevin Feeley, the Company’s current Senior Vice President of Operations and Head of GeneDx, was appointed to also serve as the Chief Financial Officer, effective August 25, 2022.
Departed
(interim)
Richard Miao
Interim Chief Financial Officer and Deputy Chief Financial Officer
On August 26, 2022, Sema4 Holdings Corp. (“Sema4 Holdings” or the “Company”) announced that its Interim Chief Financial Officer and Deputy Chief Financial Officer, Richard Miao, will leave the Company.
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
Kevin Feeley was appointed as Chief Financial Officer at GeneDx Holdings Corp..
Action
appointed
Role
Chief Financial Officer
Exact text from the filing
On August 25, 2022, Kevin Feeley, the Company’s current Senior Vice President of Operations and Head of GeneDx, was appointed to also serve as the Chief Financial Officer, effective August 25, 2022.
Richard Miao departed as Interim Chief Financial Officer and Deputy Chief Financial Officer at GeneDx Holdings Corp..
Action
will leave
Role
Interim Chief Financial Officer and Deputy Chief Financial Officer
Exact text from the filing
On August 26, 2022, Sema4 Holdings Corp. (“Sema4 Holdings” or the “Company”) announced that its Interim Chief Financial Officer and Deputy Chief Financial Officer, Richard Miao, will leave the Company.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.